Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 1c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Zimmer Biomet (ZBH) PT Raised to $127 at Canaccord Genuity
April 26, 2019 1:27 PM EDTCanaccord Genuity analyst Kyle Rose raised the price target on Zimmer Biomet (NYSE: ZBH) to $127.00 (from $125.00) while maintaining a Hold rating.
executing to plan but still early in the process... MoreZimmer Biomet (ZBH) PT Raised to $134 at RBC Capital
April 26, 2019 11:45 AM EDTRBC Capital analyst Brandon Henry raised the price target on Zimmer Biomet (NYSE: ZBH) to $134.00 (from $128.00) while maintaining a Outperform rating following results.
Long-Term Turnaround Story Unchanged;... MoreNeedham & Company Upgrades Zimmer Biomet (ZBH) to Strong Buy
April 24, 2019 6:06 AM EDTNeedham & Company analyst Mike Matson upgraded Zimmer Biomet (NYSE: ZBH) from Buy to Strong Buy with a price target of $155.00.
The analyst comments "We expect ZBHs revenue growth to accelerate during 2019 as it shifts back to offense after addressing its supply... More
